Dickinson Andrew D
SEC CIK 1310204 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GILD | Gilead Sciences | CFO | 164.1K | — | $62.18M | 94 | 2021-08-15 | 2026-09-15 |
Most active insiders at GILD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | O'Day Daniel Patrick | COB, CEO, Dir | — | $51.34M |
| 2 | Mercier Johanna | Chief Commercial Off | — | $18.52M |
| 3 | Telman Deborah H | EVP, GC, Corp. Affairs | — | $6.59M |
| 4 | Dickinson Andrew D | CFO | — | $4.68M |
| 5 | WELTERS ANTHONY | Dir | — | $2.68M |
| 6 | Bluestone Jeffrey | Dir | — | $1.97M |
| 7 | Kramer Kelly A. | Dir | — | $713.2K |
| 8 | Cain Wettan Keeley M | EVP Gen Counsel, Legal, Comp | — | — |
| 9 | Burkhart Erin | SVP, Controllership | — | — |
| 10 | Berger Dietmar | Chief Medical Off | — | — |
Transactions 94
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-16 16:30 | 2026-09-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $145.29 | -3,000 | 164.1K | -2% | -$435.9K |
| D | 2026-09-11 18:30 | 2026-09-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +2,797 | 168.4K | +2% | — |
| D | 2026-09-11 18:30 | 2026-09-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $144.81 | -1,347 | 167.1K | -0.8% | -$195.1K |
| T | 2026-08-18 19:06 | 2026-08-17 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $138.36 | -3,000 | 165.6K | -2% | -$415.1K |
| T | 2026-07-16 18:08 | 2026-07-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $129.93 | -3,000 | 168.6K | -2% | -$389.8K |
| T | 2026-06-16 17:53 | 2026-06-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $125.40 | -3,000 | 171.6K | -2% | -$376.2K |
| D | 2026-06-11 18:32 | 2026-06-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +2,796 | 176.0K | +2% | — |
| D | 2026-06-11 18:32 | 2026-06-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $121.48 | -1,341 | 174.6K | -0.8% | -$162.9K |
| T | 2026-05-18 17:50 | 2026-05-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $132.27 | -3,000 | 173.2K | -2% | -$396.8K |
| T | 2026-04-16 18:41 | 2026-04-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $140.96 | -3,000 | 176.2K | -2% | -$422.9K |
| 2026-03-17 | 2026-03-16 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $144.23 | -3,000 | 179.2K | -2% | -$432.7K | |
| D | 2026-03-12 | 2026-03-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +6,469 | 185.3K | +4% | — |
| D | 2026-03-12 | 2026-03-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $148.56 | -3,147 | 182.2K | -2% | -$467.5K |
| 2026-03-02 | 2026-02-27 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | A - Grant | $0.00 | +11.1K | 178.9K | +7% | $0 | |
| 2026-02-18 | 2026-02-17 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $154.43 | -3,000 | 167.8K | -2% | -$463.3K | |
| 2026-02-05 | 2026-02-03 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | A - Grant | $0.00 | +44.9K | 195.4K | +30% | $0 | |
| 2026-02-05 | 2026-02-03 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $143.28 | -24.8K | 170.6K | -13% | -$3.55M | |
| 2026-01-16 | 2026-01-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $124.31 | -3,000 | 150.5K | -2% | -$372.9K | |
| 2025-12-16 | 2025-12-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $122.00 | -3,000 | 153.5K | -2% | -$366.0K | |
| D | 2025-12-11 | 2025-12-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +3,693 | 158.2K | +2% | — |
| D | 2025-12-11 | 2025-12-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $121.34 | -1,745 | 156.5K | -1% | -$211.7K |
| 2025-11-18 | 2025-11-17 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $125.23 | -2,500 | 154.6K | -2% | -$313.1K | |
| 2025-10-16 | 2025-10-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $118.08 | -2,500 | 157.1K | -2% | -$295.2K | |
| 2025-09-16 | 2025-09-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $113.57 | -2,500 | 159.6K | -2% | -$283.9K | |
| D | 2025-09-11 | 2025-09-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $115.25 | -1,751 | 162.1K | -1% | -$201.8K |
| D | 2025-09-11 | 2025-09-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +3,696 | 163.8K | +2% | — |
| 2025-08-18 | 2025-08-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $118.53 | -2,500 | 160.1K | -2% | -$296.3K | |
| 2025-07-16 | 2025-07-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $111.03 | -2,500 | 162.6K | -2% | -$277.6K | |
| 2025-06-17 | 2025-06-16 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $110.17 | -2,500 | 165.1K | -1% | -$275.4K | |
| D | 2025-06-11 | 2025-06-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $110.09 | -1,758 | 167.6K | -1% | -$193.5K |
| D | 2025-06-11 | 2025-06-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +3,694 | 169.4K | +2% | — |
| 2025-05-16 | 2025-05-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $99.82 | -2,500 | 165.7K | -1% | -$249.5K | |
| 2025-04-16 | 2025-04-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $106.40 | -2,500 | 168.2K | -1% | -$266.0K | |
| 2025-03-18 | 2025-03-17 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $110.53 | -2,500 | 170.7K | -1% | -$276.3K | |
| DM | 2025-03-12 | 2025-03-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale+OE | $118.17 | -17.9K | 182.1K | -9% | -$2.12M |
| DM | 2025-03-12 | 2025-03-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | $63.91 | +25.9K | 187.0K | +16% | +$1.66M |
| D | 2025-03-12 | 2025-03-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $117.21 | -3,855 | 173.2K | -2% | -$451.8K |
| 2025-02-19 | 2025-02-18 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $104.09 | -2,500 | 169.1K | -1% | -$260.2K | |
| DM | 2025-02-13 | 2025-02-12 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | $67.27 | +137.7K | 248.9K | +124% | +$9.26M |
| D | 2025-02-13 | 2025-02-12 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale+OE | $102.22 | -137.7K | 171.2K | -45% | -$14.07M |
| 2025-02-06 | 2025-02-04 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $97.99 | -43.1K | 171.2K | -20% | -$4.23M | |
| M | 2025-02-06 | 2025-02-04 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | A - Grant | $0.00 | +84.5K | 149.7K | +130% | $0 |
| DM | 2025-02-03 | 2025-01-31 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | $67.52 | +142.2K | 227.9K | +166% | +$9.60M |
| D | 2025-02-03 | 2025-01-31 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale+OE | $97.22 | -142.2K | 129.9K | -52% | -$13.82M |
| 2025-01-16 | 2025-01-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $91.35 | -2,500 | 129.9K | -2% | -$228.4K | |
| 2024-12-17 | 2024-12-16 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $91.96 | -8,500 | 132.4K | -6% | -$781.7K | |
| D | 2024-12-11 | 2024-12-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $92.34 | -1,686 | 140.9K | -1% | -$155.7K |
| D | 2024-12-11 | 2024-12-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +3,640 | 142.6K | +3% | — |
| DM | 2024-12-03 | 2024-11-29 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | $70.50 | +248.6K | 157.5K | New | +$17.53M |
| DM | 2024-12-03 | 2024-11-29 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale+OE | $92.76 | -248.6K | 266.8K | -48% | -$23.07M |
| D | 2024-09-11 | 2024-09-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $81.44 | -1,682 | 138.9K | -1% | -$137.0K |
| D | 2024-09-11 | 2024-09-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +3,641 | 140.6K | +3% | — |
| D | 2024-06-11 | 2024-06-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +3,639 | 138.6K | +3% | — |
| D | 2024-06-11 | 2024-06-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $65.25 | -1,662 | 137.0K | -1% | -$108.4K |
| DM | 2024-03-11 | 2024-03-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +9,732 | 139.5K | +8% | — |
| D | 2024-03-11 | 2024-03-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $75.12 | -4,505 | 135.0K | -3% | -$338.4K |
| 2024-02-02 | 2024-01-31 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $78.26 | -23.4K | 129.4K | -15% | -$1.83M | |
| M | 2024-02-02 | 2024-01-31 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | A - Grant | $0.00 | +75.0K | 152.8K | +96% | $0 |
| 2024-01-17 | 2024-01-16 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $85.78 | -5,000 | 101.5K | -5% | -$428.9K | |
| D | 2023-12-11 | 2023-12-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +2,617 | 107.7K | +2% | — |
| D | 2023-12-11 | 2023-12-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $79.02 | -1,194 | 106.5K | -1% | -$94.3K |
| D | 2023-11-13 | 2023-11-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +1,912 | 105.9K | +2% | — |
| D | 2023-11-13 | 2023-11-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $75.92 | -804 | 105.1K | -0.8% | -$61.0K |
| 2023-10-18 | 2023-10-17 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $80.00 | -5,000 | 104.0K | -5% | -$400.0K | |
| D | 2023-09-11 | 2023-09-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $76.00 | -1,203 | 109.0K | -1% | -$91.4K |
| D | 2023-09-11 | 2023-09-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +2,619 | 110.2K | +2% | — |
| 2023-07-21 | 2023-07-20 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | S - Sale | $80.00 | -5,000 | 107.6K | -4% | -$400.0K | |
| D | 2023-06-12 | 2023-06-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $78.12 | -1,219 | 73.7K | -2% | -$95.2K |
| D | 2023-06-12 | 2023-06-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +2,618 | 74.9K | +4% | — |
| DM | 2023-03-13 | 2023-03-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +10.4K | 116.0K | +10% | — |
| D | 2023-03-13 | 2023-03-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $79.50 | -4,849 | 111.2K | -4% | -$385.5K |
| 2023-02-23 | 2023-02-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | A - Grant | $56.38 | +376 | 105.6K | +0.4% | +$21.2K | |
| D | 2023-02-07 | 2023-02-06 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $86.36 | -531 | 105.2K | -0.5% | -$45.9K |
| D | 2023-02-07 | 2023-02-06 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +1,817 | 105.8K | +2% | — |
| M | 2023-01-26 | 2023-01-24 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | A - Grant | $0.00 | +66.2K | 119.3K | +125% | $0 |
| 2023-01-26 | 2023-01-24 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $84.02 | -15.3K | 104.0K | -13% | -$1.29M | |
| D | 2022-12-13 | 2022-12-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $87.97 | -480 | 69.2K | -0.7% | -$42.2K |
| D | 2022-12-13 | 2022-12-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | $0.00 | +1,027 | 69.7K | +1% | $0 |
| D | 2022-11-14 | 2022-11-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +1,912 | 69.5K | +3% | — |
| D | 2022-11-14 | 2022-11-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $82.60 | -851 | 68.7K | -1% | -$70.3K |
| D | 2022-09-12 | 2022-09-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $65.28 | -476 | 67.6K | -0.7% | -$31.1K |
| D | 2022-09-12 | 2022-09-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +1,027 | 68.1K | +2% | — |
| DM | 2022-06-13 | 2022-06-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +4,672 | 69.0K | +7% | — |
| D | 2022-06-13 | 2022-06-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $60.74 | -1,969 | 67.1K | -3% | -$119.6K |
| 2022-04-13 | 2022-02-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | A - Grant | $52.13 | +348 | 64.4K | +0.5% | +$18.1K | |
| DM | 2022-03-15 | 2022-03-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +7,901 | 63.5K | +14% | — |
| D | 2022-03-15 | 2022-03-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $57.92 | -3,602 | 64.0K | -5% | -$208.6K |
| D | 2022-02-08 | 2022-02-06 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $63.90 | -767 | 59.7K | -1% | -$49.0K |
| D | 2022-02-08 | 2022-02-06 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | $0.00 | +1,817 | 60.5K | +3% | $0 |
| 2022-01-28 | 2022-01-26 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $67.34 | -3,616 | 58.7K | -6% | -$243.5K | |
| M | 2022-01-28 | 2022-01-26 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | A - Grant | $0.00 | +32.2K | 62.3K | +107% | $0 |
| D | 2021-11-12 | 2021-11-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | F - Tax | $67.32 | -870 | 38.0K | -2% | -$58.6K |
| D | 2021-11-12 | 2021-11-10 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | M - OptEx | — | +1,913 | 38.9K | +5% | — |
| 2021-08-24 | 2021-08-15 | GILD | Gilead Sciences | Dickinson Andrew D | CFO | A - Grant | $55.08 | +1 | 37.0K | +0.0% | +$55.08 |
Purchase Sale Sale after option exercise All abbreviations